U.S. Communications Stock News

NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Is It Time To Reassess Euronet Worldwide (EEFT) After A 30% One-Year Share Price Slump

If you are wondering whether Euronet Worldwide's current share price still reflects its true worth, you are not alone. This article is built to help you assess that question clearly. The stock last closed at US$70.53, with a 3.8% return over the past 7 days, but longer term returns sit at a 4.8% decline year to date and a 30.7% decline over the past year. This may have changed how some investors view its risk and potential. Recent coverage of Euronet Worldwide has focused on its position...
NYSE:PPL
NYSE:PPLElectric Utilities

PPL Equity Units Offering Fuels Grid Investment And Dividend Growth Plans

PPL Corporation (NYSE:PPL) announced a public offering of 20 million equity units. Each equity unit combines a stock purchase contract with an interest in remarketable senior notes. The transaction is structured as a capital markets offering to raise funding for the company. PPL is a regulated utility holding company focused on electricity, an area that continues to attract investor attention because of its link to essential services and long term infrastructure investment. For shareholders...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

Is Chord Energy (CHRD) Pricing Look Attractive After Recent Nasdaq Spotlight?

If you are wondering whether Chord Energy's share price still reflects good value or if the opportunity has passed, looking closely at how the market is pricing the business can give you useful clues. The stock recently closed at US$105.25, with returns of 3.2% over the past 7 days, 10.2% over the last 30 days, 11.2% year to date and a 0.3% decline over the last year, which may leave investors debating whether this is renewed enthusiasm or a reassessment of risk. Recent news flow around...
NasdaqGS:SANA
NasdaqGS:SANABiotechs

Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum

Sana Biotechnology (SANA) has been drawing attention after a mixed stretch in its share performance, with a small gain over the past week contrasting with a decline over the past month. See our latest analysis for Sana Biotechnology. At the current share price of $4.07, Sana Biotechnology has seen a 5.71% 7 day share price return and a 15.95% 90 day share price return. Its 1 year total shareholder return of 41.32% contrasts with a 5 year total shareholder return loss of 87.76%, suggesting...
NYSE:SCL
NYSE:SCLChemicals

Stepan (SCL) Thin 2% Margin And EPS Slide Reinforce Bearish Narratives In FY 2025

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...
NYSE:FET
NYSE:FETEnergy Services

Forum Energy Technologies (FET) Is Up 16.7% After Record Backlog And Buyback Completion - Has The Bull Case Changed?

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart JV With CBRE IM Tests Growth Prospects And Valuation Gap

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...
NYSE:SRE
NYSE:SREIntegrated Utilities

Is It Time To Reassess Sempra (SRE) After Strong Multi Year Share Gains

If you are wondering whether Sempra is fairly priced or if there could be value left on the table, starting with the recent share performance and valuation checks can help frame that question. Sempra shares last closed at US$93.60, with returns of 8.9% over 30 days, 4.3% year to date, 10.9% over 1 year, 33.1% over 3 years, and 86.2% over 5 years. Recent coverage of Sempra has focused on its role as a US utilities player, investor interest in income and infrastructure names, and how these...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is Harmony Biosciences (HRMY) Pricing Reflect Recent Share Slump And DCF Upside Potential

If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies. The stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks. Recent news coverage around Harmony Biosciences has focused on the...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

The Bull Case For Dollar Tree (DLTR) Could Change Following Raised EPS Guidance And Tariff Relief Hopes

Dollar Tree recently raised its full-year EPS guidance after reporting a strong quarter, including 4.2% comparable sales growth and 12% adjusted EPS growth to US$1.21, while analysts highlighted both benefits from a Supreme Court tariff ruling and concerns about valuation and limited e-commerce presence. An interesting angle is how the company’s multi-price strategy and potential tariff relief may support margin recovery even as some analysts turn cautious. Next, we’ll examine how Dollar...
NYSE:CBU
NYSE:CBUBanks

Community Financial System Adds Insurance Veteran To Deepen Board Risk Oversight

Community Financial System (NYSE:CBU) has appointed Brenda M. Hall as a new independent director to its Board. Hall previously served as chief operating officer in the insurance industry, with experience in enterprise strategy, risk management, and regulatory oversight. The appointment is intended to deepen the Board’s expertise in governance and oversight for shareholders and other stakeholders. Community Financial System, the parent of Community Bank, operates as a regional financial...
NasdaqCM:OSS
NasdaqCM:OSSTech

A Look At One Stop Systems (OSS) Valuation After New P‑8A Poseidon Contract Wins

What the new P-8A contracts tell you about OSS’s business mix One Stop Systems (OSS) has secured US$10.5 million in new awards tied to the P-8A Poseidon aircraft, the largest aggregate orders it has reported for this platform so far. For you as a shareholder or prospective investor, this indicates two things at once: confirmed demand from U.S. defense customers and clearer forward visibility, since OSS expects these awards to contribute to revenue in 2026 and continue into 2027. The contracts...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Is Freshworks (FRSH) Now Offering Opportunity After 60% One Year Share Price Slide

Investors may be wondering whether Freshworks is starting to look like value after a tough stretch, or if the market is still pricing in more risk than reward. The stock closed at US$6.88, with returns of a 5.0% decline over 7 days, 41.9% decline over 30 days, 40.7% decline year to date and 60.0% decline over the past year, which will catch the eye of anyone tracking sentiment shifts and potential reset points. Recent coverage has focused on how Freshworks fits into the broader software...
NYSE:CMC
NYSE:CMCMetals and Mining

Former CMC Executive Trims Stake As Valuation Signals Suggest Undervaluation

Former Chief HR & Communications Officer Jennifer J. Durbin sold over 32% of her direct stake in Commercial Metals in an open market transaction. The sale reduces her holding but she retains a remaining position in the company. The transaction comes with Commercial Metals, NYSE:CMC, last closing at $75.64. This kind of insider activity tends to get investors' attention because it involves someone who previously held a senior leadership role and has had visibility into the business...
NYSE:AUB
NYSE:AUBBanks

A Look At Atlantic Union Bankshares (AUB) Valuation After Recent Share Price Pullback

Atlantic Union Bankshares: Event Trigger and Recent Returns Atlantic Union Bankshares (AUB) has come onto investors’ radar after recent trading, with the stock closing at $38.87 and showing mixed short term performance, including a 4.4% decline over the past day. Over the past week the share price is down 3.4%, while the past 3 months show a 13.5% total return and the past year a 15.4% total return, raising questions about current valuation. See our latest analysis for Atlantic Union...
NYSE:PBF
NYSE:PBFOil and Gas

Is PBF Energy (PBF) Pricing Reflect Recent Refining Sector Sentiment Shifts Accurately

If you are wondering whether PBF Energy's current share price really reflects its worth, you are not alone, and this article will help you frame that question clearly. The stock last closed at US$34.32, with returns of 2.7% over 30 days, 20.3% year to date, 55.1% over 1 year, a 16.1% decline over 3 years, and 154.5% over 5 years. This gives a mixed picture of how the market has been pricing the company over time. Recent news coverage has focused on PBF Energy in the context of broader energy...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals Tanbreez Assays Highlight Heavy Rare Earth Resource Potential

Critical Metals Corp. (NasdaqGM:CRML) reported its strongest rare earth element assay results to date from the Tanbreez Heavy REE Project. The assays highlight high quality and consistent mineralization at the Hill Deposit, supporting the potential for resource expansion. The company outlined next steps toward converting these findings into resources and progressing project development. For investors following rare earths, Critical Metals sits in a space tied closely to advanced...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Sigma Lithium Supply Deal Resets Production Outlook And Investor Trade Offs

Sigma Lithium (NasdaqCM: SGML) has signed a significant supply agreement, securing long-term sales for its lithium products. The company has resumed its production cadence, including the commercialization of low grade lithium product. The agreement is supported by a sizable revolving working capital facility and a commercial partnership with a leading supply chain player. Sigma Lithium, listed on NasdaqCM under the ticker SGML, focuses on lithium production that supports battery and...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Casella Waste Systems Pursues Deal Driven Growth As Margins Come Under Strain

Casella Waste Systems (NasdaqGS:CWST) has completed nine acquisitions, adding more than $115 million in annualized revenues. The company outlined an active pipeline of additional deals it aims to pursue in 2026. Management framed the acquisition push as a key lever for scaling operations and driving efficiencies across the business. For investors following NasdaqGS:CWST, this deal streak comes at a time when the stock is trading at $92.71 and has seen a 17.2% decline over the past year,...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Will Fortrea (FTRE) Executive Shifts Refocus Its Clinical Margin Story Or Signal Strategic Drift?

On 17 February 2026, Fortrea Holdings expanded its executive team by dedicating Oren Cohen, MD solely to the chief medical officer role and appointing Scott Dove, PhD as president of Clinical Pharmacology Services, with both serving on the Executive Committee. This leadership reshaping concentrates seasoned medical and early development expertise at the top of the organization, potentially affecting how Fortrea runs trials and manages its clinical pharmacology operations. Next, we’ll examine...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Saia Faces Volume Strain As Price Hikes And Investment Hit Returns

Saia (NasdaqGS:SAIA) is facing ongoing sales volume challenges over the last two years and has leaned on price increases to support revenue. At the same time, the company has stepped up investment activity, which has pressured cash flows. Returns on capital have declined, raising questions about whether Saia’s traditional profit drivers are maturing. Saia operates in the less than truckload freight sector, where pricing power and network efficiency matter as much as demand trends. For you...
NYSE:NTST
NYSE:NTSTRetail REITs

What NETSTREIT (NTST)'s US$209 Million Equity Raise and Dividend Hike Means For Shareholders

Earlier in February 2026, NETSTREIT Corp. completed a US$208.62 million follow-on equity offering of 10,980,000 common shares at US$19.00 each, soon after reporting higher quarterly and full-year revenues and declaring a quarterly dividend of US$0.22 per share. The combination of fresh equity capital, a modest dividend increase, and a swing from loss to profit provides new context for how NETSTREIT might fund future property acquisitions and support its income-focused REIT profile. We will...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

A Look At COMPASS Pathways (CMPS) Valuation After Positive COMP360 Phase 3 Results And FDA Plans

Why COMPASS Pathways is back on investor radar COMPASS Pathways (NasdaqGS:CMPS) has attracted fresh attention after reporting highly statistically significant, clinically meaningful Phase 3 results for its COMP360 psilocybin therapy in treatment resistant depression, along with plans to seek a rolling FDA review. See our latest analysis for COMPASS Pathways. The latest COMP360 data and follow on offering come after a sharp 50.96% 90 day share price return and a 112.16% 1 year total...
NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Lincoln Educational Services (LINC) Margin Rebound Tests Premium P/E Narrative

Lincoln Educational Services (LINC) has put solid numbers on the board for FY 2025, with fourth quarter revenue of US$142.9 million and basic EPS of US$0.41, alongside trailing twelve month revenue of US$518.2 million and EPS of US$0.65. The company has seen quarterly revenue move from US$119.4 million and EPS of US$0.22 in Q4 2024 to US$142.9 million and US$0.41 respectively in Q4 2025, while trailing twelve month EPS moved from US$0.32 to US$0.65 over the same period. This sets the stage...